×
ADVERTISEMENT

cosibelimab-ipdl

FDA Approves Unloxcyt for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

The FDA approved Unloxcyt for adults with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC ...

DECEMBER 16, 2024

Load more